Sio Gene Therapies, Inc. (SIOX)
Market Open
7 Feb, 20:58
NASDAQ (NGS) NASDAQ (NGS) Primary $
0. 48
+0.09
+22.627%
$
35.36M Market Cap
- P/E Ratio
1.74% Div Yield
7,588 Volume
- Eps
$ 0.39
Previous Close Want to track SIOX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sio Gene Therapies, Inc. (SIOX) Statistics
Valuation metrics
Market Cap 35.36M
Enterprise value -61.21M
Trailing P/E (ttm) -0.49
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) -
Price/Book (mrq) 0.58
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.86
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 0.25
52-Week high 0.5
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:8
Last split Date 8 May 2019
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.96%
Return on equity -0.78%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.98
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.87
Total debt (mrq) -
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 5.52%
Book value per share (mrq) 0.82
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
